Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**9% Saline (NS)** is a typographical error in clinical trial registries (such as NCT02477449) representing **0.9% Saline** (Normal Saline), which is a sterile, isotonic solution of sodium chloride (NaCl) in water. It contains 9 grams of sodium chloride per liter (0.9% w/v), matching the osmolarity of normal human extracellular fluid. Normal saline is widely used in clinical practice for intravenous hydration, extracellular fluid replacement, and as a vehicle or diluent for the administration of compatible intravenous drugs. In clinical trials, such as the Phase 1 study of istaroxime sponsored by Lee's Pharmaceutical, normal saline is frequently employed as an inert placebo or comparator control. It has no specific biological target or disease-modifying mechanism of action, and is not a therapeutic agent for acute heart failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on normal saline.